Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
26,828,643
-
Total 13F shares
-
2,623,150
-
Share change
-
+345,514
-
Total reported value
-
$18,886,000
-
Price per share
-
$7.20
-
Number of holders
-
13
-
Value change
-
+$2,666,855
-
Number of buys
-
9
-
Number of sells
-
5
Institutional Holders of Eton Pharmaceuticals, Inc. - Common Stock (ETON) as of Q4 2019
As of 31 Dec 2019,
Eton Pharmaceuticals, Inc. - Common Stock (ETON) was held by
13 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,623,150 shares.
The largest 10 holders included
Opaleye Management Inc., AWM Investment Company, Inc., VANGUARD GROUP INC, PRELUDE CAPITAL MANAGEMENT, LLC, BlackRock Inc., ROYAL BANK OF CANADA, Centric Wealth Management, FIRST TRUST ADVISORS LP, NORTHERN TRUST CORP, and WELLS FARGO & COMPANY/MN.
This page lists
13
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.